A clinical study of commonly isolated organism and its antibiotic sensitivity in diabetic foot ulcers in Sri Manakula Vinayagar Medical College and Hospital, Pondicherry


  • Anand Shanmugaiah Department of General Surgery, Sri Manakula Vinayagar Medical College, Pondicherry, India
  • Saravanan Pandian Department of General Surgery, Indira Gandhi Medical College and Research Institute, Pondicherry, India
  • Sudha Selvam Department of Microbiology, Sri Manakula Vinayagar Medical College, Pondicherry, India




Diabetic foot ulcer, Amputation, Polymicrobial infection, Bacterial isolates, Antibiotic susceptibility pattern


Background: Diabetic foot ulcer is one of the major surgical problem leading to hospital admission. Diabetic foot ulcer patients with uncontrolled diabetes may end up in forefoot amputation. Early aggressive debridement, control of blood sugar and empirical antibiotic therapy would reduce the morbidities in patients with diabetic foot ulcer. Further the knowledge of commonly isolated microbes and their antibiotic sensitivity pattern would be helpful to start empirical therapy. The purpose of this study was to determine the microbiological profile of diabetic foot infections (DFIs) and assess the antibiotic susceptibility of the causative agents.

Methods: This cross-sectional study was conducted in 115 patients admitted with diabetic foot ulcer over a period of 9 months from October 2015 to June 2016 at the department of general surgery, Sri Manakula Vinayagar Medical College and Hospital, Pondicherry. Tissue scrapping samples were collected and processed as per standard guidelines.

Results: 167 organisms were isolated from 115 patients. 52% of culture showed polymicrobial growth. There was increased prevalence of gram-negative organisms 53% compared to gram positive organisms 47%. When comes to individual isolate, Staphylococcus aureus was the most common organism isolated 24.6% followed by Pseudomonas aeruginosa 21%. All gram-positive aerobes were sensitive to vancomycin and gram-negative isolates were sensitive to amikacin, piperacillin-tazobactum, gentamycin and cefotaxime.

Conclusions: Staphylococcus aureus and Pseudomonas were the common pathogens isolated. This study recommends use of vancomycin along with piperacillin-tazobactum as an empirical therapy along with adequate blood sugar control and early debridement of devitalized tissues in patients with diabetic foot infections.


Joshi SR, Parikh RM. India diabetes capital of the world: now heading towards hypertension. J Assoc Physicians India. 2007;55:323-4.

Kumar A, Goel MK, Jain RB, Khanna P, Chaudary V. India towards diabetes control: Key issues. Australs Med J. 2013;6(10):524-31.

Hena VJ, Growther L. Studies on Bacterial Infections of Diabetic Foot Ulcer. Afr J Cln Exper Microbiol. 2010;11(3):146-9.

Zaini A. Where is Malaysia in the midst of the Asian epidemic of diabetes mellitus. Diabetes Res Clin Pract. 2000;50(2):23-8.

Ramsey SD, Newton K, Blough D, McCulloch DK, Sandhu N, Reiber GE, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care. 1999;22:287-382.

Gadepalli R, Dhawan B, Sreenivas V, Kapil A, Ammini AC, Chaudhry R. A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital. Diabetes Care. 2006;29:1727-32.

Jeffcoate WJ, Harding KG. Diabetic foot ulcers. Lancet. 2003;361:1545-51.

Lipsky BA. A report from the international consensus on diagnosing and treating the infected diabetic foot. Diabetes Metab Res Rev. 2004;20(1):68-77.

Bansal E, Garg A, Bhatia S, Attri AK, Chander J. Spectrum of microbial flora in diabetic foot ulcers. Indian J Pathol Microbiol. 2008;51:204-8.

Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54:132-73.

Frykberg RG. An evidence-based approach to diabetic foot infections. Am J Surg. 2003;186:44-54.

Lipsky BA, Berendt AR, Deery HG, Embil JM, Joseph WS, Karchmer AW, et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2004;39:885-910.

Mansilha A, Brandao D. Guidelines for treatment of patients with diabetes and infected ulcers. J Cardiovasc Surg. 2013;54:193-200.

Lipsky BA, Sanchez AJ, Diggle M. IWGDF guidance on the diagnosis and management of foot infections in patients with diabetes. Diabetes Metabolism Res Reviews. 2016;32(1):45-74.

Bowler PG, Duerden BI, Amstrong DG. Wound microbiology and associated approaches to wound management. Clin Microbiology Reviews. 2001;14(2):244-69.

Sotto A, Richard JL, Jourdan N, Combescure C, Bouziges N, Lavigne JP. Miniaturized Oligonucleotide arrays: a new tool for discriminating colonization from infection due to Staphylococcus aureus in diabetic foot ulcers. Diabetes Care. 2007;30(8):2051-6.

Clinical and Laboratory Standards Institute. Performance standard for antimicrobial susceptibility testing; 22 informational supplements. Clinical and Laboratory Standards Institute, Wayne, PA, USA. 2012;32(3):100-22.

Abdulrazak A, Bitar ZI, Shamali AA, Mobasher LA. Bacteriological study of diabetic foot infections. J Diabet Complications. 2005;19:138-41.

Goldstein EJ, Citron DM, Nesbit CA. Diabetic foot infections: bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive cases. Diabetes Care. 1996;19:638-64.

Benwan AK, Mulla AA, Rotimi VO. A study of the microbiology of diabetic foot infections in a teaching hospital in Kuwait. J Infect Public Health. 2012;5:1-8.






Original Research Articles